ATP5PB and Alzheimer disease: The frontal cortex of AD patient brains at Braak stages V/VI was assessed for a variety of oxidative protein modifications, and a four-fold increase in Nε-(malondialdehyde)-lysine (MDAL) modification of mitochondrial ATP synthase subunit β (Pamplona, 2005).